ECRG2 enhances the anti-cancer effects of cisplatin in cisplatin-resistant esophageal cancer cells via upregulation of p53 and downregulation of PCNA

doi:10.3748/wjg.v23.i10.1796

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7134)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series.

Item

Count

PDF

407

WORD

286

HTML

3264

Figures (1-6)

311

Sum=4268

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

938

Download

1928

Sum=2866

Mar 14, 2017 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Mar 14, 2017; 23(10): 1796-1803
Published online Mar 14, 2017. doi: 10.3748/wjg.v23.i10.1796

Full Size Figure Download Figure

Figure 6 Effects of esophageal cancer-related gene 2 and cisplatin (DDP) on the expression of proliferating cell nuclear antigen, p53, and metallothionein proteins. I: Drug-resistant cell group; II: DDP group; III: DDP + esophageal cancer-related gene 2 (ECRG2) group. Data were expressed as the mean ± SD, n = 3. ^aP < 0. 05 vs control; ^cP < 0.05 vs control; ^eP < 0.05 vs DDP groups.

Citation: Hou XF, Xu LP, Song HY, Li S, Wu C, Wang JF. ECRG2 enhances the anti-cancer effects of cisplatin in cisplatin-resistant esophageal cancer cells via upregulation of p53 and downregulation of PCNA. World J Gastroenterol 2017; 23(10): 1796-1803
URL: https://www.wjgnet.com/1007-9327/full/v23/i10/1796.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i10.1796